SG17493G - Ozone decontamination of blood and blood products - Google Patents

Ozone decontamination of blood and blood products

Info

Publication number
SG17493G
SG17493G SG174/93A SG17493A SG17493G SG 17493 G SG17493 G SG 17493G SG 174/93 A SG174/93 A SG 174/93A SG 17493 A SG17493 A SG 17493A SG 17493 G SG17493 G SG 17493G
Authority
SG
Singapore
Prior art keywords
blood
products
ozone
ozone decontamination
physiological
Prior art date
Application number
SG174/93A
Other languages
English (en)
Original Assignee
Medizone Int Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medizone Int Inc filed Critical Medizone Int Inc
Publication of SG17493G publication Critical patent/SG17493G/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
    • A61L2/0094—Gaseous substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
    • A61L2/20—Gaseous substances, e.g. vapours
    • A61L2/202—Ozone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1698—Blood oxygenators with or without heat-exchangers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/32—Oxygenators without membranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/02—Gases
    • A61M2202/0216—Ozone
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SG174/93A 1985-04-03 1993-02-17 Ozone decontamination of blood and blood products SG17493G (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/719,187 US4632980A (en) 1985-04-03 1985-04-03 Ozone decontamination of blood and blood products

Publications (1)

Publication Number Publication Date
SG17493G true SG17493G (en) 1993-04-16

Family

ID=24889094

Family Applications (1)

Application Number Title Priority Date Filing Date
SG174/93A SG17493G (en) 1985-04-03 1993-02-17 Ozone decontamination of blood and blood products

Country Status (8)

Country Link
US (1) US4632980A (fr)
EP (1) EP0199479B1 (fr)
JP (1) JPS6221A (fr)
AT (1) ATE57474T1 (fr)
CA (1) CA1269935A (fr)
DE (1) DE3674941D1 (fr)
HK (1) HK45193A (fr)
SG (1) SG17493G (fr)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5281392A (en) * 1986-03-10 1994-01-25 Rubinstein Alan I Method for disinfecting red blood cells, blood products, and corneas
US5211912A (en) * 1986-08-01 1993-05-18 University Of Southern California Method for disinfecting red blood cells, blood products, and corneas
US4971760A (en) * 1986-03-10 1990-11-20 University Of Southern California Novel method for disinfecting red blood cells, blood platelets, blood plasma, and optical corneas and sclerae
US5185371A (en) * 1986-03-10 1993-02-09 University Of Southern California Method for disinfecting red blood cells
AU6942387A (en) * 1986-08-01 1988-03-24 Rubinstein, A.I. A method to treat blood
US4944920A (en) * 1986-08-01 1990-07-31 University Of Southern California Novel method to treat blood
FR2603805A1 (fr) * 1986-09-16 1988-03-18 Transfusion Sanguine Assoc Rgl Procede d'inactivation par ozonolyse de micro-organismes contaminants presents dans des materiaux biologiques essentiellement proteiques, les produits obtenus et leurs applications biologiques et analytiques
DE3674213D1 (de) * 1986-10-30 1990-10-18 Horst Dr Med Kief Verfahren zur herstellung von keimabgetoeteten oder in ihrer virulenz abgeschwaechten substanzen sowie deren verwendung.
US6303152B1 (en) * 1986-10-30 2001-10-16 Horst Kief Process for the production of substances that have been bactericidally treated and/or exhibit immune-modulatory activity, and the use thereof
IL86417A (en) * 1987-05-22 1992-09-06 Armour Pharma Process for the inactivation of pathogens in biological or pharmaceutical material by mixing with aqueous solution containing a sugar(alcohol)and neutral salts as stabilizers
EP0339924B1 (fr) * 1988-04-29 1995-03-29 Medizone International, Inc. Appareil pour la génération et l'administration contrôlée d'ozone
US4983637A (en) * 1988-06-24 1991-01-08 Stephen Herman Method for treating viral infection of HIV
US5270344A (en) * 1988-06-24 1993-12-14 Stephen Herman Method of treating a systemic disorder using trioxolane and diperoxide compounds
US5126376A (en) * 1988-06-24 1992-06-30 Stephen Herman Method for treating viral infection using topical administration
US5086076A (en) * 1988-06-24 1992-02-04 Stephen Herman Antiviral pharmaceutical compositions comprising a terpene ozonide
US5260342A (en) * 1988-06-24 1993-11-09 Stephen Herman Method for treating viral infection parenterally
US5364879A (en) * 1988-06-24 1994-11-15 Cliveden Ltd. Medical uses of trioxolane and diperoxide compounds
US5190977A (en) * 1988-06-24 1993-03-02 Stephen Herman Antiviral compositions
US5093326A (en) * 1989-06-19 1992-03-03 Stephen Herman Repellant compositions
AU637374B2 (en) * 1990-06-04 1993-05-27 Medizone International, Inc. Ozone decontamination of blood and blood products
GB9617611D0 (en) * 1996-08-22 1996-10-02 Vasogen Inc Treatment of autoimmune disease
EP1243278B1 (fr) * 1992-02-07 2007-01-03 Vasogen Ireland Limited Utilisation du sang comprenant une concentration d'oxyde nitrique augmentée pour la préparation d'un médicament
US5591457A (en) * 1992-02-07 1997-01-07 Vasogen Inc Method of inhibiting the aggregation of blood platelets and stimulating the immune systems of a human
US5980954A (en) 1992-02-07 1999-11-09 Vasogen Ireland Limited Treatment of autoimmune diseases
US6204058B1 (en) 1992-02-07 2001-03-20 Vasogen Ireland Limited Treatment of autoimmune diseases
US6669965B2 (en) 1992-02-07 2003-12-30 Vasogen Ireland Limited Method of treating atherosclerosis
US6696092B2 (en) 1992-02-07 2004-02-24 Vasogen Ireland Limited Endothelial lining effects and treatment of vasospastic disorders
FR2692486A1 (fr) * 1992-06-23 1993-12-24 Abdelmassih Zaki George Procédé et dispositif de stérilisation du sang des malades du SIDA ou d'une autre maladie bactérienne, parasitaire ou virale du sang.
WO1994003217A1 (fr) * 1992-07-31 1994-02-17 Wainwright Basil E Appareil et procede d'inactivation du virus de l'immunodeficience humaine
FR2694886A1 (fr) * 1992-08-06 1994-02-25 Zaki George Procédé et dispositif pour stériliser le sang des malades du sida, de la malaria ou d'une autre maladie bactérienne, parasitaire ou virale du sang.
DE4340730C2 (de) * 1993-12-01 1995-10-05 Waltraud Kockerols Verbindungssystem für die hyperbare Ozontherapie an einem Patienten
GB9502347D0 (en) * 1995-02-07 1995-03-29 Ca Nat Research Council Method and apparatus for inactivation of viruses in body fluids
US5540898A (en) * 1995-05-26 1996-07-30 Vasogen Inc. Ozone generator with in-line ozone sensor
US5741894A (en) * 1995-09-22 1998-04-21 Baxter International, Inc. Preparation of pharmaceutical grade hemoglobins by heat treatment in partially oxygenated form
WO1998009513A1 (fr) * 1996-09-06 1998-03-12 Lifetech Corporation Methode et appareil de sterilisation de substrats biologiques
WO1998015297A1 (fr) * 1996-10-09 1998-04-16 Lifetech Corporation Procede de sterilisation de matieres biologiques
CA2274461A1 (fr) 1996-12-03 1998-06-11 Lisa Marlene Jeffreys Smith Intermediaires d'oxygene reactifs contenant des composes aptes a induire la differenciation cellulaire de cellules malignes, telles que la leucemie
US20040022666A1 (en) * 1998-06-30 2004-02-05 Invitrogen Corporation Methods for reducing adventitious agents and toxins and cell culture reagents produced thereby
US6383810B2 (en) * 1997-02-14 2002-05-07 Invitrogen Corporation Dry powder cells and cell culture reagents and methods of production thereof
US20060003447A1 (en) * 2003-12-30 2006-01-05 Richard Fike Dry powder cells and cell culture reagents and methods of production thereof
US6627426B2 (en) 1997-02-14 2003-09-30 Invitrogen Corporation Methods for reducing adventitious agents and toxins and cell culture reagents produced thereby
EP1091765A4 (fr) * 1998-06-30 2001-10-24 Invitrogen Corp Procedes servant a reduire des agents et des toxines adventices et reactifs de cultures cellulaires obtenus au moyen de ces agents et de ces toxines
WO2001089601A1 (fr) * 2000-05-24 2001-11-29 Medizone International, Inc. Procede et dispositif de decontamination par l'ozone de liquides biologiques
EP2295533A3 (fr) * 2000-11-06 2011-07-13 Life Technologies Corporation Réactifs sèches de culture cellulaire, et méthodes de production correspondantes
US20030228564A1 (en) * 2001-05-30 2003-12-11 Edrich Richard Alan Nitric oxide in a pathogen inactivation process
WO2003020103A2 (fr) * 2001-09-04 2003-03-13 Amit Technology Science & Medicine Ltd. Procede et dispositif pour la stimulation lumineuse therapeutique d'organes et de tissus internes
US20030073945A1 (en) * 2001-10-17 2003-04-17 Liang-Kuang Diang Ozone hemodiafiltration device
AU2002367942A1 (en) * 2001-11-02 2003-12-22 Medizone International, Inc. Method and apparatus for ozone decontamination of biological liquids
WO2003048313A2 (fr) * 2001-11-30 2003-06-12 Invitrogen Corporation Produits de culture cellulaire sous forme de poudre seche contenant des lipides et procedes de production correspondants
US7118852B2 (en) * 2002-04-11 2006-10-10 Throwleigh Technologies, L.L.C. Methods and apparatus for decontaminating fluids
MXPA04010027A (es) * 2002-04-12 2005-07-01 Throwleigh Technologies L L C Metodos y aparatos para descontaminar fluidos.
JP3890044B2 (ja) 2003-02-18 2007-03-07 シャープ株式会社 活性化ガスが抗原性物質を失活させる性能の評価方法、その評価方法の評価試料として用いる処理済抗原性物質の作成装置
CN1832756A (zh) 2003-06-09 2006-09-13 约翰·A·麦金太尔 通过氧化还原反应改变血浆蛋白质结合专一性的方法
US7736494B2 (en) * 2003-07-31 2010-06-15 Acquisci, Inc. Ozone delivery system including a variable pitch gas-fluid contact device
US20100316727A1 (en) * 2003-07-31 2010-12-16 Latino Joseph S Treatment of inflammatory disorders with ozone
WO2005018715A1 (fr) * 2003-07-31 2005-03-03 Lipidviro Tech Systeme de distribution d'ozone comportant des dispositifs de mise en contact gaz/fluide et procedes d'utilisation
US20100318014A1 (en) * 2003-07-31 2010-12-16 Latino Joseph S Treatment of acute ischemic brain stroke with ozone
US20100316730A1 (en) * 2003-07-31 2010-12-16 Latino Joseph S Treatment of cardiovascular diseases with ozone
US20050189302A1 (en) * 2003-07-31 2005-09-01 Latino Joseph S. Viral inactivation using ozone
US7615030B2 (en) * 2003-10-06 2009-11-10 Active O, Llc Apparatus and method for administering a therapeutic agent into tissue
US8066659B2 (en) * 2004-06-15 2011-11-29 Ceramatec, Inc. Apparatus and method for treating and dispensing a material into tissue
US8777889B2 (en) * 2004-06-15 2014-07-15 Ceramatec, Inc. Apparatus and method for administering a therapeutic agent into tissue
US20060273045A1 (en) * 2005-06-03 2006-12-07 BAGLEY David Method of spinning water and oxygen for producing super-oxygenated and structured water
US8353906B2 (en) * 2005-08-01 2013-01-15 Ceramatec, Inc. Electrochemical probe and method for in situ treatment of a tissue
EP1779891A1 (fr) * 2005-10-28 2007-05-02 Abdula Kurkayev Méthode d'activation d'un photosensibilisateur
ITMI20131667A1 (it) * 2013-10-09 2015-04-10 Ind Paolo Gobbi Frattini Metodo per pre-trattare le cellule ematiche prima della separazione.
EP3500277A4 (fr) 2016-08-19 2020-04-15 Immunores-Therapeutics, LLC Systèmes et procédés de distribution d'un gaz de traitement
WO2018035504A1 (fr) 2016-08-19 2018-02-22 Lane Ronald Howard Systèmes et procédés de distribution d'un gaz de traitement

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4183962A (en) * 1978-01-16 1980-01-15 Exxon Research & Engineering Co. Process for oxygenating blood by the utilization of liquid membranes
NZ203094A (en) * 1982-02-09 1986-04-11 Univ California Vaccines with ozone-treated microorganisms
US4581231A (en) * 1982-06-10 1986-04-08 The United States Of America As Represented By The Secretary Of Health And Human Services Inactivation of viruses containing essential lipids
US4540573A (en) * 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
DE3325568A1 (de) * 1983-07-15 1985-01-24 Erwin Sander Elektroapparatebau GmbH, 3162 Uetze Verfahren zur schonenden ozonbehandlung von fluessigkeiten, wie etwa fruchtsaefte, milch, fluessige milchprodukte, wein, oele, fluessige medikamente, blut und oder aehnliche produkte

Also Published As

Publication number Publication date
EP0199479A2 (fr) 1986-10-29
ATE57474T1 (de) 1990-11-15
DE3674941D1 (de) 1990-11-22
US4632980B1 (fr) 1990-06-26
JPH0471892B2 (fr) 1992-11-16
EP0199479B1 (fr) 1990-10-17
US4632980A (en) 1986-12-30
JPS6221A (ja) 1987-01-06
EP0199479A3 (en) 1987-08-26
CA1269935A (fr) 1990-06-05
HK45193A (en) 1993-05-14

Similar Documents

Publication Publication Date Title
US4632980B1 (fr)
OA08581A (en) Treatment of diseases caused by retroviruses.
DE69008664D1 (de) Bestrahlung von bluterzeugnissen.
FI946004A (fi) Lääketieteellisessä toimenpiteessä käytettävä trombiiniverifraktio
BG60253B1 (bg) Човешки тъканен плазминогенен активатор
ZM9387A1 (en) Treatment of diseases caused by viruses
GR3005040T3 (fr)
DE3777861D1 (de) Behandlung von gasen.
DE3684755D1 (de) Behandlung von tieren mit il-2, zubereitungen dafuer und ihre herstellung.
EP0325129A3 (en) Disubstituted pyridines
AU2158688A (en) Use of bezafibrate for treating diabetes
ES8704962A1 (es) Un procedimiento para preparar 1b-d-ribofuranosil, 1-2-4-triazol-3-carboxamida.
AU569354B2 (en) (-)-1,7-diphenyl-3-methylaza-7-cyano-8-methylnonane
DE3674321D1 (de) Behandlung geschmeidiger gewebe.
IT8620561A0 (it) Procedimento e dispositivo per il trattamento di prodotti di uovo, o relativi composti, per prolungare la durata dei prodotti medesimi.
ZA893310B (en) Novel strobilurine derivatives,their preparation and their use
DE3462891D1 (en) New pyrimidine derivatives endowed with antiviral activity
GR3005231T3 (fr)
EP0264017A3 (en) Pharmaceutical compositions having healing activity
AU588493B2 (en) Treatment of diseases caused by viruses
DE3788424D1 (de) Testverfahren des menschlichen b-lymphotropen virus (hblv).
DE68906028D1 (de) Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom.
DE3770742D1 (de) Behandlung von sichelzellanaemie.
EP0228034A3 (en) Arginine and agmatine derivatives for treating protozoal infections
AU1618892A (en) Treatment of human viral infection by dsrna combined with viral inhibitors